Results 151 to 160 of about 900,457 (343)

Hypersonic test facility Patent [PDF]

open access: yes, 1966
Hypersonic test facility for studying ablation in models under high pressure and high ...
Buchanan, R. I.   +3 more
core   +1 more source

Kilohertz laser ablation for doping helium nanodroplets

open access: yes, 2007
A new setup for doping helium nanodroplets by means of laser ablation at kilohertz repetition rate is presented. The doping process is characterized and two distinct regimes of laser ablation are identified.
B. Forkl   +6 more
core   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

open access: yesMolecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez   +17 more
wiley   +1 more source

Ablation [PDF]

open access: yes, 2016
Edison Wong, Richard Kunz
openaire   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

open access: yesMolecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

Combined Plasma and Laser Heating of Graphite

open access: yesPlasma
This paper investigates a novel combined laser and plasma heating test technique. Integrating the 1.5 kW Raycus RFL-C1500 laser source into the VGU-4 Inductively Coupled Plasma Facility (IPMech RAS) allowed the study of fine-grain MPG-7 graphite ablation
Aleksey Chaplygin   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy